Global tissue banking market will reach $44.08 billion by 2030, growing by 8.3% annually over 2020-2030 owing to the increasing demand for regenerative medicines and advancements in tissue preservation and in-house sample testing, an increasing number of biobanks across the globe, and the advancements in the medical drug discovery and biopharmaceuticals industry.
Highlighted with 83 tables and 92 figures, this 173-page report Global Tissue Banking Market 2020-2030 by Offering (Equipment, Accessories & Consumables, Services), Application (Therapeutics, Medical Research, Cosmetics), Tissue Type (Cardiovascular, Corneal, Lung, Kidney, Bone, Skin), End User, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global tissue banking market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global tissue banking market in every aspect of the classification from perspectives of Offering, Application, Tissue Type, End User, and Region.

Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Equipment
o Cryopreservation Equipment
o Thawing Equipment
o Quality Control Equipment
o Labeling and Coding Equipment
o Alarming and Monitoring Systems
o Other Equipment
Accessories and Consumables
Services
o Screening
o Processing
o Tissue Retrieval
o Testing
o Storage and Preservation
o Other Services

Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Therapeutics
Medical Research
Cosmetics
Other Applications

Based on Tissue Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Cardiovascular Tissue
Corneal Tissue
Lungs Tissue
Kidney Tissue
Bone Tissue
Skin Tissue
Brain & Spinal Cord
Others Tissue Types

Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Biobanks
Hospitals and Clinics
Research and Academic Institutes
Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
North America (U.S., Canada, and Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
South America (Brazil, Chile, Argentina, Rest of South America)
MEA (UAE, Saudi Arabia, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Offering, Application, and Tissue Type over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
AMS Biotechnology Ltd.
Avantor Inc. (VWR International)
Beckman Coulter, Inc.
Bio-Rad Laboratories Inc.
Bluechiip Limited
Brooks Lifesciences (Brooks Automation Inc.)
Custom Biogenic Systems, Inc.
Eppendorf AG
Hamilton Company
Merck KGaA
Organ Recovery Systems, Inc.
PHC Holdings Corporation
Sartorius AG
Taylor-Wharton International LLC
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)